Skip to main content

Table 2 Microbiological findings in REF, ABROAD and ICU

From: Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital

 

REF

ABROAD

ICU

number of patients

117

84

495

patients positive for at least one MDRGN (n;%; 95% CI)

61; 52.1; 42.7-61.5

35; 41.6; 31.0-52.9

39; 7.9; 5.6-10.6

subgroup surgery

 

general / vascular

4; 66.7; 22.2-96.6

1; 25; 0.6-80.6

22; 14.4; 9.2-20.9

thoracic

-

1; 50; 12.6-98.7

14; 5.1; 2.8-8.5

traumatology

3; 42.9; 9.9-81.6

2; 33.3; 4.3-77.7

3; 4.3; 0.9-12.2

patients positive for at least one MDRGN with CR (n;%; 95%CI)

1; 0.9; 0.0-4.7

13; 15.5; 8.5-25.0

0; 0; 0.0-0.7

total number of MDRGN

66

48

40

total number of MDRGN with CR

1

19

-

Escherichia coli

 

ESBL (n;%; 95CI)

24; 20.5; 13.6-28.9

5; 5.9; 1.9-13.3

14; 2.8; 1.5-4.7

ESBL/FQ (n;%;95CI)

34; 29.1; 21.0-38.2

17; 20.2; 12.3-30.4

19; 3.8; 2.3-5.9

ESBL/FQ + CR (n;%;95CI)

1; 0.9; 0.0-4.7

2; 2.4; 0.3-8.3

-

carbapenemases (n)

none detected (1)

OXA-181 + NDM-5 (1)

none detected (1)

-

Klebsiella pneumoniae

 

ESBL (n;%;95CI)

3; 2.6; 0.5-7.3

-

1; 0.2; 0.0-1.1

ESBL/FQ (n;%;95CI)

4; 3.4; 0.9-8.5

5; 5.9; 1.9-13.3

2; 0.4; 0.0-1.5

ESBL/FQ + CR (n;%;95CI)

-

7; 8.3; 3.4-16.4

-

carbapenemases (n)

-

OXA-48 (2)

OXA-181 (1)

KPC-3 (1)

KPC-9 (1)

NDM-1 (1)

none detected (1)

-

other Enterobacteriaceae

 

Ceph/FQ (n;%;95CI)

-

2 a; 2.4; 0.3-8.3

4 b; 0.8; 0.2-2.1

Ceph/FQ + CR (n;%;95CI)

-

1 c; 1.2; 0.0-6.5

-

carbapenemase (n)

-

none detected (1)

-

Acinetobacter baumannii

 

Ceph/FQ (n;%;95CI)

Ceph/FQ + CR (n;%;95CI)

-

-

-

-

8; 9.5; 4.2-17.9

-

carbapenemase (n) d

-

OXA-23 (4)

OXA-24 (1)

OXA-58 (1)

NDM-1 + OXA-23 (1)

OXA-23 + OXA-24 (1)

-

Pseudomonas aeruginosa

 

Pip/Ceph/FQ + CR (n;%;95CI)

-

1; 1.2; 0.0-6.5

-

carbapenemase (n)

-

none detected (1)

-

patients positive for MRSA (n;%; 95% CI)

12; 10.3; 5.4-17.2

4; 4.8; 1.3-11.7

7; 1.4; 0.6-2.9

spa types (n)

t304 (2)

t4892 (2)

  

t044 (1)

t131 (1)

t311 (1)

t325 (1)

t386 (1)

t003 (1)

t217 (1)

t325 (1)

t608 (1)

t020 (2)

t003 (1)

t223 (1)

t309 (1)

t668 (1)

t3758 (1)

t688 (1)

t790 (1)

t3422 (1)

  
  1. Abbreviations: CR carbapenem resistance, ESBL extended spectrum beta-lactamase, ESBL/FQ ESBL and additional resistance to fluoroquinolones, Ceph/FQ resistance to cephalosporins and additionally to fluoroquinolones, Pip/Ceph/FQ + CR resistance to Piperacillin and additionally Ceph/FQ + CR, MRSA methicillin-resistant Staphylococcus aureus
  2. (a) = Morganella morganii, Proteus mirabilis (n = 1 each); (b) = Enterobacter cloacae, Serratia marcescens, Proteus mirabilis, and Morganella morganii (n = 1 each); (c) = Proteus mirabilis; (d) = other than species-specific OXA-51